Format
Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 1 to 20 of 169

1.

Uterine smooth muscle tumors of uncertain malignant potential (STUMP): a clinicopathologic analysis of 16 cases.

Ip PP, Cheung AN, Clement PB.

Am J Surg Pathol. 2009 Jul;33(7):992-1005. doi: 10.1097/PAS.0b013e3181a02d1c.

PMID:
19417585
3.

Differential expression of P16 and P21 in benign and malignant uterine smooth muscle tumors.

Ünver NU, Acikalin MF, Öner Ü, Ciftci E, Ozalp SS, Colak E.

Arch Gynecol Obstet. 2011 Aug;284(2):483-90. doi: 10.1007/s00404-010-1690-z. Epub 2010 Sep 28.

PMID:
20878171
4.

Atypical leiomyomas of the uterus with long-term follow-up after myomectomy with immunohistochemical analysis for p16INK4A, p53, Ki-67, estrogen receptors, and progesterone receptors.

Sung CO, Ahn G, Song SY, Choi YL, Bae DS.

Int J Gynecol Pathol. 2009 Nov;28(6):529-34. doi: 10.1097/PGP.0b013e3181a2b8d3.

PMID:
19851199
5.

Expression of p16 protein in patients with uterine smooth muscle tumors: an immunohistochemical analysis.

Bodner-Adler B, Bodner K, Czerwenka K, Kimberger O, Leodolter S, Mayerhofer K.

Gynecol Oncol. 2005 Jan;96(1):62-6.

PMID:
15589581
6.
7.

Uterine smooth muscle tumors of uncertain malignant potential (STUMP): pathology, follow-up and recurrence.

Dall'Asta A, Gizzo S, Musarò A, Quaranta M, Noventa M, Migliavacca C, Sozzi G, Monica M, Mautone D, Berretta R.

Int J Clin Exp Pathol. 2014 Oct 15;7(11):8136-42. eCollection 2014.

8.

Differential diagnosis of smooth muscle tumors utilizing p53, pTEN and Ki-67 expression with estrogen and progesterone receptors.

Gökaslan H, Türkeri L, Kavak ZN, Eren F, Sişmanoğlu A, Ilvan S, Durmuşoğlu F.

Gynecol Obstet Invest. 2005;59(1):36-40. Epub 2004 Sep 20.

PMID:
15377824
10.

[Progress in clinicopathologic study on uterine smooth muscle tumor of uncertain malignant potential].

Deng ZJ, Guo LN.

Zhonghua Bing Li Xue Za Zhi. 2011 Aug;40(8):573-6. Review. Chinese. No abstract available.

PMID:
22169655
11.

Fascin expression in uterine smooth muscle tumors.

Kefeli M, Yildiz L, Kaya FC, Aydin O, Kandemir B.

Int J Gynecol Pathol. 2009 Jul;28(4):328-33. doi: 10.1097/PGP.0b013e318195da9f.

PMID:
19483633
12.
13.

[Smooth muscle tumor of uncertain malignant potential (STUMP)--clinico-pathomorphological analysis of the cases and literature review].

Dańska-Bidzińska A, Bakuła-Zalewska E, Nasierowska-Guttmejer A, Kowalewska M, Barnaś E, Sobiczewski P, Bidziński M.

Ginekol Pol. 2012 Jun;83(6):412-6. Review. Polish.

PMID:
22880459
14.

Uterine smooth muscle tumors of uncertain malignant potential and atypical leiomyoma: a morphological study of these grey zones with clinical correlation.

Deodhar KK, Goyal P, Rekhi B, Menon S, Maheshwari A, Kerkar R, Tongaonkar HB.

Indian J Pathol Microbiol. 2011 Oct-Dec;54(4):706-11. doi: 10.4103/0377-4929.91500.

15.

The Use of p16 in enhancing the histologic classification of uterine smooth muscle tumors.

Atkins KA, Arronte N, Darus CJ, Rice LW.

Am J Surg Pathol. 2008 Jan;32(1):98-102.

PMID:
18162776
16.

Inguinal smooth muscle tumors in women-a dichotomous group consisting of Müllerian-type leiomyomas and soft tissue leiomyosarcomas: an analysis of 55 cases.

Patil DT, Laskin WB, Fetsch JF, Miettinen M.

Am J Surg Pathol. 2011 Mar;35(3):315-24. doi: 10.1097/PAS.0b013e318208e361.

PMID:
21297441
18.
19.

Immunohistochemical analysis of p16, p53, and Ki-67 expression in uterine smooth muscle tumors.

Chen L, Yang B.

Int J Gynecol Pathol. 2008 Jul;27(3):326-32. doi: 10.1097/PGP.0b013e31815ea7f5.

PMID:
18580309
20.

Atypical intradermal smooth muscle neoplasms: clinicopathologic analysis of 84 cases and a reappraisal of cutaneous "leiomyosarcoma".

Kraft S, Fletcher CD.

Am J Surg Pathol. 2011 Apr;35(4):599-607. doi: 10.1097/PAS.0b013e31820e6093.

PMID:
21358302
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk